The (cost)-effectiveness of a lifestyle intervention for male workers at risk for cardiovascular disease in the contruction industry in The Netherlands

ISRCTN ISRCTN60545588
DOI https://doi.org/10.1186/ISRCTN60545588
Submission date
22/01/2007
Registration date
22/01/2007
Last edited
26/02/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Ms I F Groeneveld
Scientific

VU University Medical Center
EMGO-Institute
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Phone +31 (0)20 444 6496
Email iris.groeneveld@vumc.nl

Study information

Study designRandomised, controlled, parallel group, single blinded trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleThe (cost)-effectiveness of a lifestyle intervention for male workers at risk for cardiovascular disease in the contruction industry in The Netherlands
Study objectivesParticipants in the intervention group, receiving an individual lifestyle intervention, will improve lifestyle and Cardiovascular Disease (CVD)-risk related biomedical outcome values at the short (six months) and the longer (12 months) term, whereas in the control group these variables will remain the same as at baseline.
Ethics approval(s)Approval received from the Ethics Committee of the VU Medical Centre ('Medisch Ethische Toetseingscommissie VU medisch centrum') on 3rd April 2007 (ref: 2006/291).
Health condition(s) or problem(s) studiedCardiovascular disease
InterventionIntervention:
Individual counselling about improving the energy balance (diet and physical activity) or smoking cessation, in the form of Motivational Interviewing, with the stages of change as a basis.

Duration is six months, in which three face to face contacts at the Occupational Health Service and four telephone contacts with a professional health counsellor (OP or nurse) will take place. Additional written information about a healthy lifestyle will also be provided.

Control:
Care as usual.
Intervention typeOther
Primary outcome measure1. Dietary intake:
a. fruits, vegetables and fish
b. snacks, soda, and alcohol intake
c. slices of bread, plates for dinner
2. Physical activity:
a. fulfilling the NNGB and the Fitnorm
b. frequency, duration and intensity of habitual PA in leisure time
3. smoking status: smoker/ non-smoker
Secondary outcome measures1. BMI (kg/ m^2)
2. Systolic and diastolic blood pressure (mmHg)
3. High Density Lipoprotein (HDL)-cholesterol and total cholesterol (mmol/litre)
4. HbA1C (%)
5. Cardio-respiratory fitness
6. Stage of change
7. Behaviour determinants
8. Perceived general health
9. Absenteeism
10. Cost-effectiveness
Overall study start date01/04/2007
Completion date01/10/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexMale
Target number of participants700
Key inclusion criteria1. Male
2. 18 to 55 years
3. Available for the study for the following 12 months
4. Signed an informed consent form
5. At risk for CVD according to the Framingham risk score, and one or more of the following other risk factors:
a. fulfilling none of the Dutch Physical Activity (PA) standards (Nederlandse Norm Gezond Bewegen [NNGB] and Fitnorm)
c. alcohol use: more than 35 glasses of alcohol per week
d. HbA1c more than 6.5%
e. Body Mass Index (BMI) more than 30 kg/m^2
f. tiredness or stress and/or treated for psychological disorders and/or low motivation to recover
h. shortness of breath and/or suffering from chest pain and/or diagnosed with or treated for CVD or its predictors (e.g. high blood pressure)
Key exclusion criteria1. Unable to be physically active
2. Not sufficiently capable of using the Dutch language
3. Not having signed an informed consent form
Date of first enrolment01/04/2007
Date of final enrolment01/10/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

VU University Medical Center
Amsterdam
1081 BT
Netherlands

Sponsor information

VU University Medical Centre (The Netherlands)
Hospital/treatment centre

EMGO-Institute
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands

Phone +31 (0)20 444 8180
Email emgo@vumc.nl
Website http://www.vumc.nl/english/
ROR logo "ROR" https://ror.org/00q6h8f30

Funders

Funder type

Research organisation

Arbouw Foundation (Stichting Arbouw) (The Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 03/01/2008 Yes No
Results article results 01/12/2009 26/02/2021 Yes No
Results article results 31/10/2011 26/02/2021 Yes No

Editorial Notes

26/02/2021: Publication references added.
06/11/2019: Internal review.